Latest Diabetic Nephropathy News
Study: ESRD Risk in Type 1 Diabetes Pts Has Declined
Relative risk of end-stage renal disease was 0.13 in those diagnosed in 1995-2011 versus 1965-1979.
SHPT Highly Prevalent Among Diabetic Nephropathy Patients
Nearly 86% of diabetic nephropathy patients from an Egyptian outpatient center had elevated iPTH levels.
End-Stage Renal Disease From Diabetes Declined in US
2000 to 2014 saw decrease in incidence of ESRD with diabetes listed as the primary cause.
Anemia Risk Factors in Diabetic Nephropathy Patients Identified
Proteinuria and renin-angiotensin-aldosterone system inhibitors are independently associated with a significant 6-fold increased odds for anemia in patients with diabetic nephropathy.
Glycemic Control Intensity Does Not Influence ESRD, Mortality
End-stage renal disease developed in similar proportions of diabetics regardless of whether they had intensive or standard glycemic control.
Biomarkers Predict Rapid Renal Decline in Type 2 Diabetes
Biomarkers apoA4, CD5L, C1QB, and IBP3 may improve the prediction of rapid decline in renal function independently of recognized clinical risk factors in T2DM.
Liraglutide Linked With Lower Diabetic Kidney Disease Risk
Liraglutide-treated patients were 22% less likely than placebo recipients to experience a composite outcome of renal events.
Adynamic Bone Disease Prevalent in Type 2 Diabetes Patients With CKD
Almost 40% of pre-dialysis patients with stage 4-5 CKD patients and type 2 diabetes had lab results suggesting low turnover bone disease.
Low Tryptophan May Signal Diabetic Nephropathy
There was a significant association for Trp with the event of rapid decline in eGFR.
sRAGE May Increase Risk of Diabetic Nephropathy
Higher levels of sRAGE were significantly associated with incidence of DN after adjustment for duration of diabetes.
Children With Diabetic Ketoacidosis at High Risk of AKI
Of the children who developed acute kidney injury, 34.9% had stage 1, 45.3% had stage 2, and 19.8% had stage 3.
Increased Use of DPP-4, SGLT-2 Inhibitors for Diabetic Nephropathy
DPP-4 inhibitors use was used in 54% of treatment visits by the last quarter of 2014; ACEIs and ARBs were prescribed in the majority of treatment visits with peaks above 90%.
Valsartan Reduces Microalbuminuria in IGT Patients
Valsartan reduced the incidence of microalbuminuria in IGT without increasing the incidence of hyperkalemia or renal dysfunction compared with placebo.
T2DM Microvascular Complications Linked to Periodontitis Severity
Poor glycemic control linked to increased prevalence and severity of periodontitis.
Liraglutide Found to Reduce Albuminuria in Diabetes Patients
Use of the glucagon-like peptide-1 receptor agonist lowered 24-hour urinary albumin excretion rate by 32% over 12 weeks versus placebo.
Newsletter Signup
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Anemia
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetes
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Hemodialysis
- Hyperphosphatemia
- Hypertension
- Hyperuricemia
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)
- Transplantation